. 2020 Nov 26;8(22):5576–5588. doi: 10.12998/wjcc.v8.i22.5576
©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
Figure 1.
Flow chart of study inclusion. T2D: Type 2 diabetes; DPP4i: Dipeptidyl peptidase-4 inhibitors.